VSM Wealth Advisory’s Ginkgo Bioworks DNA Stock Holding History

VSM Wealth Advisory’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.91K	Hold	1,000	–	–	﹤0.01%	363
2026 Q1	$6.13K	Hold	1,000	–	–	﹤0.01%	397
2025 Q4	$8.31K	Hold	1,000	–	–	﹤0.01%	351
2025 Q3	$14.6K	Hold	1,000	–	–	﹤0.01%	307
2025 Q2	$11.3K	Hold	1,000	–	–	﹤0.01%	367
2025 Q1	$5.7K	Buy	+1,000	New	+$10.2K	﹤0.01%	397

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

VSM Wealth Advisory's DNA Position: Q2 2026 in Review

VSM Wealth Advisory held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 1,000 shares worth $9.91K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

VSM Wealth Advisory first reported a position in DNA in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.6K in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

VSM Wealth Advisory held 1,000 shares of Ginkgo Bioworks worth $9.91K as of Q2 2026.
VSM Wealth Advisory left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #363 holding.
VSM Wealth Advisory first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 6 quarters since.
VSM Wealth Advisory's Ginkgo Bioworks position peaked at $14.6K in Q3 2025.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.